{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:30:25Z","timestamp":1786350625063,"version":"build-2736575974"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01908-4","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:43:43Z","timestamp":1786344223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging roles of mitophagy in liver fibrosis: Implications for therapy"],"prefix":"10.1038","author":[{"given":"Zi-yang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-na","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-juan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"1908_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1908_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.32163","volume":"75","author":"P Gines","year":"2022","unstructured":"Gines P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, et al. Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022;75:219\u201328.","journal-title":"Hepatology"},{"key":"1908_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101231","volume":"95","author":"M Parola","year":"2024","unstructured":"Parola M, Pinzani M. Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies. Mol Aspects Med. 2024;95:101231.","journal-title":"Mol Aspects Med"},{"key":"1908_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/S0140-6736(26)00354-5","volume":"407","author":"I Graupera","year":"2026","unstructured":"Graupera I, Thiele M, Castera L, Pera G, Piano S, S\u00f2ria A, et al. Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study. Lancet. 2026;407:1448\u201358.","journal-title":"Lancet"},{"key":"1908_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","volume":"23","author":"M Zamani","year":"2025","unstructured":"Zamani M, Alizadeh-Tabari S, Ajmera V, Singh S, Murad MH, Loomba R. Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2025;23:1123\u201334.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1908_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337.","journal-title":"J Hepatol"},{"key":"1908_CR7","first-page":"463","volume":"11","author":"S Kim","year":"2026","unstructured":"Kim S, Oh J, Shin JI, Aalruz H, Abbas N, Abdulmalik AE, et al. Global burden of metabolic dysfunction-associated steatotic liver disease, 1990\u20132023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Gastroenterol. 2026;11:463\u201394.","journal-title":"Lancet Gastroenterol"},{"key":"1908_CR8","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/liv.14940","volume":"41","author":"D Cheng","year":"2021","unstructured":"Cheng D, Chai J, Wang H, Fu L, Peng S, Ni X. Hepatic macrophages: key players in the development and progression of liver fibrosis. Liver Int. 2021;41:2279\u201394.","journal-title":"Liver Int"},{"key":"1908_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.gendis.2021.12.006","volume":"10","author":"HV Charan","year":"2023","unstructured":"Charan HV, Dwivedi DK, Khan S, Jena G. Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: therapeutic potential for liver fibrosis. Genes Dis. 2023;10:480\u201394.","journal-title":"Genes Dis"},{"key":"1908_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105433","volume":"165","author":"XL Wang","year":"2021","unstructured":"Wang XL, Feng ST, Wang ZZ, Chen NH, Zhang Y. Role of mitophagy in mitochondrial quality control: mechanisms and potential implications for neurodegenerative diseases. Pharmacol Res. 2021;165:105433.","journal-title":"Pharmacol Res"},{"key":"1908_CR11","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/HEP.0000000000000319","volume":"78","author":"Y Song","year":"2023","unstructured":"Song Y, Wei J, Li R, Fu R, Han P, Wang H, et al. Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-beta\/SMAD signaling. Hepatology. 2023;78:1433\u201347.","journal-title":"Hepatology"},{"key":"1908_CR12","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3390\/nu14122410","volume":"14","author":"L Qiao","year":"2022","unstructured":"Qiao L, Guo Z, Liu H, Liu J, Lin X, Deng H, et al. Protective effect of mitophagy regulated by mTOR signaling pathway in liver fibrosis associated with selenium. Nutrients. 2022;14:2410.","journal-title":"Nutrients"},{"key":"1908_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115717","volume":"268","author":"L Zhu","year":"2023","unstructured":"Zhu L, Zhang Q, Hua C, Ci X. Melatonin alleviates particulate matter-induced liver fibrosis by inhibiting ROS-mediated mitophagy and inflammation via Nrf2 activation. Ecotoxicol Environ Saf. 2023;268:115717.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1908_CR14","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.3390\/ijms24065465","volume":"24","author":"A Tsuji","year":"2023","unstructured":"Tsuji A, Yoshikawa S, Ikeda Y, Taniguchi K, Sawamura H, Morikawa S, et al. Tactics with prebiotics for the treatment of metabolic dysfunction-associated fatty liver disease via the improvement of mitophagy. Int J Mol Sci. 2023;24:5465.","journal-title":"Int J Mol Sci"},{"key":"1908_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13578-022-00889-1","volume":"12","author":"MF Wu","year":"2022","unstructured":"Wu MF, Zhang GD, Liu TT, Shen JH, Cheng JL, Shen J, et al. Hif-2alpha regulates lipid metabolism in alcoholic fatty liver disease through mitophagy. Cell Biosci. 2022;12:198.","journal-title":"Cell Biosci"},{"key":"1908_CR16","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104705","volume":"40","author":"M Onishi","year":"2021","unstructured":"Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 2021;40:e104705.","journal-title":"EMBO J"},{"key":"1908_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06804-5","volume":"15","author":"M Yang","year":"2024","unstructured":"Yang M, Wei X, Yi X, Jiang DS. Mitophagy-related regulated cell death: molecular mechanisms and disease implications. Cell Death Dis. 2024;15:505.","journal-title":"Cell Death Dis"},{"key":"1908_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics. 2023;13:736\u201366.","journal-title":"Theranostics"},{"key":"1908_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00018-022-04385-0","volume":"79","author":"J Cai","year":"2022","unstructured":"Cai J, Huang J, Yang J, Chen X, Zhang H, Zhu Y, et al. The protective effect of selenoprotein M on non-alcoholic fatty liver disease: the role of the AMPKalpha1-MFN2 pathway and Parkin mitophagy. Cell Mol Life Sci. 2022;79:354.","journal-title":"Cell Mol Life Sci"},{"key":"1908_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.freeradbiomed.2021.11.008","volume":"179","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Wu R, Wang X, Jiang Y, Xu W, Shao Y, et al. Activation of UQCRC2-dependent mitophagy by tetramethylpyrazine inhibits MLKL-mediated hepatocyte necroptosis in alcoholic liver disease. Free Radic Biol Med. 2022;179:301\u201316.","journal-title":"Free Radic Biol Med"},{"key":"1908_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102305","volume":"52","author":"Z Liu","year":"2022","unstructured":"Liu Z, Wang M, Wang X, Bu Q, Wang Q, Su W, et al. XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biol. 2022;52:102305.","journal-title":"Redox Biol"},{"key":"1908_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41422-025-01203-7","volume":"36","author":"Q Wang","year":"2026","unstructured":"Wang Q, Sun Y, Li TY, Auwerx J. Mitophagy in the pathogenesis and management of disease. Cell Res. 2026;36:11\u201337.","journal-title":"Cell Res"},{"key":"1908_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13327","volume":"55","author":"C Song","year":"2022","unstructured":"Song C, Pan S, Zhang J, Li N, Geng Q. Mitophagy: a novel perspective for insighting into cancer and cancer treatment. Cell Prolif. 2022;55:e13327.","journal-title":"Cell Prolif"},{"key":"1908_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/cells11010038","volume":"11","author":"V Choubey","year":"2021","unstructured":"Choubey V, Zeb A, Kaasik A. Molecular mechanisms and regulation of mammalian mitophagy. Cells. 2021;11:38.","journal-title":"Cells"},{"key":"1908_CR25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1080\/15548627.2021.1975914","volume":"18","author":"T Zhang","year":"2022","unstructured":"Zhang T, Liu Q, Gao W, Sehgal SA, Wu H. The multifaceted regulation of mitophagy by endogenous metabolites. Autophagy. 2022;18:1216\u201339.","journal-title":"Autophagy"},{"key":"1908_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02065-w","volume":"21","author":"Y Guan","year":"2021","unstructured":"Guan Y, Wang Y, Li B, Shen K, Li Q, Ni Y, et al. Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics. Cancer Cell Int. 2021;21:350.","journal-title":"Cancer Cell Int"},{"key":"1908_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","volume":"18","author":"P Teresak","year":"2022","unstructured":"Teresak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A. Regulation of PRKN-independent mitophagy. Autophagy. 2022;18:24\u201339.","journal-title":"Autophagy"},{"key":"1908_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.molmed.2022.06.007","volume":"28","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady A, Chiong M, Lavandero S, Klionsky DJ, Ren J. Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment. Trends Mol Med. 2022;28:836\u201349.","journal-title":"Trends Mol Med"},{"key":"1908_CR29","doi-asserted-by":"crossref","unstructured":"Padelli M, Hamelin J, Desterke C, Sebagh M, Saffroy R, Sanchez CG, et al. Analysis of the mitochondrial dynamics in NAFLD: Drp1 as a marker of inflammation and fibrosis. Int J Mol Sci. 2025;26:7373.","DOI":"10.3390\/ijms26157373"},{"key":"1908_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.freeradbiomed.2024.10.259","volume":"225","author":"JH Lee","year":"2024","unstructured":"Lee JH, Seo KH, Yang JH, Cho SS, Kim NY, Kim JH, et al. CCCP induces hepatic stellate cell activation and liver fibrogenesis via mitochondrial and lysosomal dysfunction. Free Radic Biol Med. 2024;225:181\u201392.","journal-title":"Free Radic Biol Med"},{"key":"1908_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2022.04.008","volume":"610","author":"ZX Xu","year":"2022","unstructured":"Xu ZX, Li JZ, Li Q, Xu MY, Li HY. CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis. Biochem Biophys Res Commun. 2022;610:35\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"1908_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jhep.2023.03.039","volume":"79","author":"K Jin","year":"2023","unstructured":"Jin K, Shi Y, Zhang H, Zhangyuan G, Wang F, Li S, et al. A TNFalpha\/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis. J Hepatol. 2023;79:403\u201316.","journal-title":"J Hepatol"},{"key":"1908_CR33","first-page":"253","volume":"73","author":"H He","year":"2024","unstructured":"He H, Tang Y, Zhuang L, Zheng Y, Huang X. PINK1\/Park2-mediated mitophagy relieve non-alcoholic fatty liver disease. Physiol Res. 2024;73:253\u201363.","journal-title":"Physiol Res"},{"key":"1908_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113043","volume":"164","author":"Q Wang","year":"2022","unstructured":"Wang Q, Jia F, Guo C, Wang Y, Zhang X, Cui Y, et al. PINK1\/Parkin-mediated mitophagy as a protective mechanism against AFB(1)-induced liver injury in mice. Food Chem Toxicol. 2022;164:113043.","journal-title":"Food Chem Toxicol"},{"key":"1908_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13378","volume":"56","author":"C Lu","year":"2023","unstructured":"Lu C, Ge T, Shao Y, Cui W, Li Z, Xu W, et al. ZNF281 drives hepatocyte senescence in alcoholic liver disease by reducing HK2-stabilized PINK1\/Parkin-mediated mitophagy. Cell Prolif. 2023;56:e13378.","journal-title":"Cell Prolif"},{"key":"1908_CR36","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1093\/cvr\/cvaa340","volume":"117","author":"T Saito","year":"2021","unstructured":"Saito T, Hamano K, Sadoshima J. Molecular mechanisms and clinical implications of multiple forms of mitophagy in the heart. Cardiovasc Res. 2021;117:2730\u201341.","journal-title":"Cardiovasc Res"},{"key":"1908_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05091-2","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R, Xu C, Zhang W, Cao Y, Ye J, Li B, et al. FUNDC1-mediated mitophagy and HIF1alpha activation drives pulmonary hypertension during hypoxia. Cell Death Dis. 2022;13:634.","journal-title":"Cell Death Dis"},{"key":"1908_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114891","volume":"197","author":"H Liu","year":"2022","unstructured":"Liu H, Zang C, Yuan F, Ju C, Shang M, Ning J, et al. The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases. Biochem Pharmacol. 2022;197:114891.","journal-title":"Biochem Pharmacol"},{"key":"1908_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41392-019-0094-1","volume":"4","author":"H Zhou","year":"2019","unstructured":"Zhou H, Zhu P, Wang J, Toan S, Ren J. DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy. Signal Transd Target Ther. 2019;4:56.","journal-title":"Signal Transd Target Ther"},{"key":"1908_CR40","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1080\/15548627.2020.1755120","volume":"17","author":"M Marinkovic","year":"2021","unstructured":"Marinkovic M, Sprung M, Novak I. Dimerization of mitophagy receptor BNIP3L\/NIX is essential for recruitment of autophagic machinery. Autophagy. 2021;17:1232\u201343.","journal-title":"Autophagy"},{"key":"1908_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04469-y","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Zheng W, Lu Y, Zheng Y, Pan L, Wu X, et al. BNIP3L\/NIX-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death Dis. 2021;13:14.","journal-title":"Cell Death Dis"},{"key":"1908_CR42","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1080\/15548627.2022.2162245","volume":"19","author":"V Madhu","year":"2023","unstructured":"Madhu V, Hernandez-Meadows M, Boneski PK, Qiu Y, Guntur AR, Kurland IJ, et al. The mitophagy receptor BNIP3 is critical for the regulation of metabolic homeostasis and mitochondrial function in the nucleus pulposus cells of the intervertebral disc. Autophagy. 2023;19:1821\u201343.","journal-title":"Autophagy"},{"key":"1908_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106517","volume":"168","author":"M Tian","year":"2024","unstructured":"Tian M, Hou J, Liu Z, Li Z, Huang D, Zhang Y, et al. BNIP3 in hypoxia-induced mitophagy: Novel insights and promising target for non-alcoholic fatty liver disease. Int J Biochem Cell Biol. 2024;168:106517.","journal-title":"Int J Biochem Cell Biol"},{"key":"1908_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2024.04.214","volume":"219","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yang F, Shi Y, Sheng J, Wang Y, Zhang L, et al. RNF31 alleviates liver steatosis by promoting p53\/BNIP3-related mitophagy in hepatocytes. Free Radic Biol Med. 2024;219:163\u201379.","journal-title":"Free Radic Biol Med"},{"key":"1908_CR45","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/hep.31987","volume":"74","author":"W Yang","year":"2021","unstructured":"Yang W, He H, Wang T, Su N, Zhang F, Jiang K, et al. Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice. Hepatology. 2021;74:2774\u201390.","journal-title":"Hepatology"},{"key":"1908_CR46","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","volume":"35","author":"H Rho","year":"2023","unstructured":"Rho H, Terry AR, Chronis C, Hay N. Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab. 2023;35:1406\u201323 e8.","journal-title":"Cell Metab"},{"key":"1908_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13158","volume":"55","author":"S Yuan","year":"2022","unstructured":"Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1alpha\/SLC7A11 pathway. Cell Prolif. 2022;55:e13158.","journal-title":"Cell Prolif"},{"key":"1908_CR48","doi-asserted-by":"crossref","unstructured":"Wang H, Wang G, Yin T, Li H, Wang H, Shao Y, et al. AMPK maintains the activation of hepatic stellate cells through mitophagy-induced metabolic reprogramming. J Mol Cell Biol. 2025;17:mjaf030.","DOI":"10.1093\/jmcb\/mjaf030"},{"key":"1908_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00431-4","volume":"18","author":"NV Pervushin","year":"2023","unstructured":"Pervushin NV, Kopeina GS, Zhivotovsky B. Bcl-B: an \u201cunknown\u201d protein of the Bcl-2 family. Biol Direct. 2023;18:69.","journal-title":"Biol Direct"},{"key":"1908_CR50","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar PE, Garcia-Saez AJ. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol. 2023;24:732\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1908_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0199-6","volume":"51","author":"Q Ding","year":"2019","unstructured":"Ding Q, Xie XL, Wang MM, Yin J, Tian JM, Jiang XY, et al. The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Exp Mol Med. 2019;51:1\u201313.","journal-title":"Exp Mol Med"},{"key":"1908_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41420-024-02072-6","volume":"10","author":"Z Liu","year":"2024","unstructured":"Liu Z, Fan K, Abudukeremu A, Gao M, Tan X, Mao X, et al. LIMA1 links the E3 ubiquitin ligase RNF40 to lipid metabolism. Cell Death Discov. 2024;10:298.","journal-title":"Cell Death Discov"},{"key":"1908_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415941","volume":"12","author":"F Yang","year":"2025","unstructured":"Yang F, Chen Y, Zheng G, Gu K, Fan L, Li T, et al. LIMA1 O-GlcNAcylation promotes hepatic lipid deposition through inducing beta-catenin-regulated FASn expression in metabolic dysfunction-associated steatotic liver disease. Adv Sci. 2025;12:e2415941.","journal-title":"Adv Sci"},{"key":"1908_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s11658-024-00596-4","volume":"29","author":"S Li","year":"2024","unstructured":"Li S, Yang F, Cheng F, Zhu L, Yan Y. Lipotoxic hepatocyte derived LIMA1 enriched small extracellular vesicles promote hepatic stellate cells activation via inhibiting mitophagy. Cell Mol Biol Lett. 2024;29:82.","journal-title":"Cell Mol Biol Lett"},{"key":"1908_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/cbdd.14063","volume":"100","author":"M Wen","year":"2022","unstructured":"Wen M, Xu H, Peng H, Sheng Y, Yang W, Yan J. MiR-27a-3p targets USP46 to inhibit the cell proliferation of hepatocellular carcinoma. Chem Biol Drug Des. 2022;100:280\u20139.","journal-title":"Chem Biol Drug Des"},{"key":"1908_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.130816","volume":"368","author":"L Zhang","year":"2022","unstructured":"Zhang L, Dong L, Yang L, Luo Y, Chen F. MiR-27a-5p regulates acrylamide-induced mitochondrial dysfunction and intrinsic apoptosis via targeting Btf3 in rats. Food Chem. 2022;368:130816.","journal-title":"Food Chem"},{"key":"1908_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.156085","volume":"165","author":"J Wang","year":"2023","unstructured":"Wang J, Ma Y, Wang J. miR-27a-5p inhibits acute rejection of liver transplantation in rats by inducing M2 polarization of Kupffer cells through the PI3K\/Akt pathway. Cytokine. 2023;165:156085.","journal-title":"Cytokine"},{"key":"1908_CR58","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.omtn.2021.10.022","volume":"26","author":"X Luo","year":"2021","unstructured":"Luo X, Xu ZX, Wu JC, Luo SZ, Xu MY. Hepatocyte-derived exosomal miR-27a activateshepatic stellate cells through the inhibitionof PINK1-mediated mitophagy in MAFLD. Mol Ther Nucleic Acids. 2021;26:1241\u201354.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1908_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117084","volume":"178","author":"S Chen","year":"2024","unstructured":"Chen S, Li Q, Shi H, Li F, Duan Y, Guo Q. New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases. Biomed Pharmacother. 2024;178:117084.","journal-title":"Biomed Pharmacother"},{"key":"1908_CR60","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/antiox12020480","volume":"12","author":"X Wen","year":"2023","unstructured":"Wen X, Tang L, Zhong R, Liu L, Chen L, Zhang H. Role of mitophagy in regulating intestinal oxidative damage. Antioxidants. 2023;12:480.","journal-title":"Antioxidants"},{"key":"1908_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41569-020-0433-5","volume":"18","author":"C Matyas","year":"2021","unstructured":"Matyas C, Hasko G, Liaudet L, Trojnar E, Pacher P. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nat Rev Cardiol. 2021;18:117\u201335.","journal-title":"Nat Rev Cardiol"},{"key":"1908_CR62","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41401-021-00681-w","volume":"43","author":"WJ Zhao","year":"2022","unstructured":"Zhao WJ, Bian YP, Wang QH, Yin F, Yin L, Zhang YL, et al. Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress. Acta Pharmacol Sin. 2022;43:645\u201358.","journal-title":"Acta Pharmacol Sin"},{"key":"1908_CR63","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/D0FO02736G","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Wang T, Liu P, Yang F, Wang X, Zheng W, et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct. 2021;12:3898\u2013918.","journal-title":"Food Funct"},{"key":"1908_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.114646","volume":"252","author":"C Song","year":"2023","unstructured":"Song C, Zhang A, Zhang M, Song Y, Huangfu H, Jin S, et al. Nrf2\/PINK1-mediated mitophagy induction alleviates sodium fluoride-induced hepatic injury by improving mitochondrial function, oxidative stress, and inflammation. Ecotoxicol Environ Saf. 2023;252:114646.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1908_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102049","volume":"45","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jasper H, Toan S, Muid D, Chang X, Zhou H. Mitophagy coordinates the mitochondrial unfolded protein response to attenuate inflammation-mediated myocardial injury. Redox Biol. 2021;45:102049.","journal-title":"Redox Biol"},{"key":"1908_CR66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15548627.2022.2084862","volume":"19","author":"L Su","year":"2023","unstructured":"Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023;19:401\u201314.","journal-title":"Autophagy"},{"key":"1908_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00601-0","volume":"12","author":"J Chen","year":"2024","unstructured":"Chen J, Wu L, Li Y. FGL1 and FGL2: emerging regulators of liver health and disease. Biomark Res. 2024;12:53.","journal-title":"Biomark Res"},{"key":"1908_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109631","volume":"117","author":"R Tao","year":"2023","unstructured":"Tao R, Han M, Yuan W, Xiao F, Huang J, Wang X, et al. Fibrinogen-like protein 2 promotes proinflammatory macrophage polarization and mitochondrial dysfunction in liver fibrosis. Int Immunopharmacol. 2023;117:109631.","journal-title":"Int Immunopharmacol"},{"key":"1908_CR69","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/cbin.11533","volume":"45","author":"W Xu","year":"2021","unstructured":"Xu W, Wang C, Hua J. X-box binding protein 1 (XBP1) function in diseases. Cell Biol Int. 2021;45:731\u20139.","journal-title":"Cell Biol Int"},{"key":"1908_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2024.0441","volume":"31","author":"J Tak","year":"2025","unstructured":"Tak J, Kim YS, Kim SG. Roles of X-box binding protein 1 in liver pathogenesis. Clin Mol Hepatol. 2025;31:1\u201331.","journal-title":"Clin Mol Hepatol"},{"key":"1908_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100555","volume":"4","author":"Q Wang","year":"2022","unstructured":"Wang Q, Bu Q, Liu M, Zhang R, Gu J, Li L, et al. XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression. JHEP Rep. 2022;4:100555.","journal-title":"JHEP Rep"},{"key":"1908_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238.","journal-title":"Mol Metab"},{"key":"1908_CR73","doi-asserted-by":"crossref","unstructured":"Li F, Yu J, Wang S, Yang X, Yao H, Pan K, et al. Mechanistic study on nonylphenol-induced liver fibrosis via Pink1\/Parkin-mediated mitophagy and lipid droplet degradation in hepatic stellate cells. Ecotoxicol Environ Saf. 2025;305:119206.","DOI":"10.1016\/j.ecoenv.2025.119206"},{"key":"1908_CR74","doi-asserted-by":"crossref","unstructured":"Chen L, Li Y, Zambidis A, Papadopoulos V. ATAD3A: a key regulator of mitochondria-associated diseases. Int J Mol Sci. 2023;24:12511.","DOI":"10.3390\/ijms241512511"},{"key":"1908_CR75","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/brv.12373","volume":"93","author":"J Baudier","year":"2017","unstructured":"Baudier J. ATAD3 proteins: brokers of a mitochondria\u2013endoplasmic reticulum connection in mammalian cells. Biol Rev. 2017;93:827\u201344.","journal-title":"Biol Rev"},{"key":"1908_CR76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41422-022-00766-z","volume":"33","author":"XQ Xie","year":"2023","unstructured":"Xie XQ, Yang Y, Wang Q, Liu HF, Fang XY, Li CL, et al. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Res. 2023;33:215\u201328.","journal-title":"Cell Res"},{"key":"1908_CR77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-017-0002-1","volume":"19","author":"G Jin","year":"2017","unstructured":"Jin G, Xu C, Zhang X, Long J, Rezaeian AH, Liu C, et al. Atad3a suppresses Pink1-dependent mitophagy to maintain homeostasis of hematopoietic progenitor cells. Nat Immunol. 2017;19:29\u201340.","journal-title":"Nat Immunol"},{"key":"1908_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34710-x","volume":"13","author":"R Undamatla","year":"2023","unstructured":"Undamatla R, Fagunloye OG, Chen J, Edmunds LR, Murali A, Mills A, et al. Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis. Sci Rep. 2023;13:7575.","journal-title":"Sci Rep"},{"key":"1908_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102008","volume":"298","author":"L Chen","year":"2022","unstructured":"Chen L, Li Y, Sottas C, Lazaris A, Petrillo SK, Metrakos P, et al. Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria. J Biol Chem. 2022;298:102008.","journal-title":"J Biol Chem"},{"key":"1908_CR80","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2012.09.010","volume":"151","author":"A Fedorenko","year":"2012","unstructured":"Fedorenko A, Lishko PV, Kirichok Y. Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell. 2012;151:400\u201313.","journal-title":"Cell"},{"key":"1908_CR81","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12944-024-02300-z","volume":"23","author":"D Gong","year":"2024","unstructured":"Gong D, Lei J, He X, Hao J, Zhang F, Huang X, et al. Keys to the switch of fat burning: stimuli that trigger the uncoupling protein 1 (UCP1) activation in adipose tissue. Lipids Health Dis. 2024;23:322.","journal-title":"Lipids Health Dis"},{"key":"1908_CR82","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cmet.2021.11.003","volume":"34","author":"EL Mills","year":"2022","unstructured":"Mills EL, Harmon C, Jedrychowski MP, Xiao H, Gruszczyk AV, Bradshaw GA, et al. Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation. Cell Metab. 2022;34:140\u201357.e8.","journal-title":"Cell Metab"},{"key":"1908_CR83","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42255-021-00389-5","volume":"3","author":"EL Mills","year":"2021","unstructured":"Mills EL, Harmon C, Jedrychowski MP, Xiao H, Garrity R, Tran NV, et al. UCP1 governs liver extracellular succinate and inflammatory pathogenesis. Nat Metab. 2021;3:604\u201317.","journal-title":"Nat Metab"},{"key":"1908_CR84","doi-asserted-by":"crossref","unstructured":"Kataoka N, Takeuchi T, Kusudo T, Li Y, Endo Y, Yamashita H. Lack of UCP1 stimulates fatty liver but mediates UCP1-independent action of beige fat to improve hyperlipidemia in ApoE knockout mice. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165762.","DOI":"10.1016\/j.bbadis.2020.165762"},{"key":"1908_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06910-4","volume":"15","author":"M Gu","year":"2024","unstructured":"Gu M, Zhang Y, Lin Z, Hu X, Zhu Y, Xiao W, et al. Decrease in UCP1 by sustained high lipid promotes NK cell necroptosis to exacerbate nonalcoholic liver fibrosis. Cell Death Dis. 2024;15:518.","journal-title":"Cell Death Dis"},{"key":"1908_CR86","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1080\/07853890.2022.2132418","volume":"54","author":"Y Meng","year":"2022","unstructured":"Meng Y, Zhao T, Zhang Z, Zhang D. The role of hepatic microenvironment in hepatic fibrosis development. Ann Med. 2022;54:2829\u201343.","journal-title":"Ann Med"},{"key":"1908_CR87","doi-asserted-by":"crossref","unstructured":"Xie D, Huang Y, Yu Y, Jin W, Zhang X, Yu F. Interactions between hepatic stellate cells and immune cells: implications for liver fibrosis. Biochim Biophys Acta Mol Basis Dis. 2026;1872:168062.","DOI":"10.1016\/j.bbadis.2025.168062"},{"key":"1908_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/ijmm.2022.5213","volume":"51","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen C, Su Y, Ke N. Function and characteristics of TIM\u20114 in immune regulation and disease. Int J Mol Med. 2022;51:10.","journal-title":"Int J Mol Med"},{"key":"1908_CR89","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/cei\/uxae063","volume":"218","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang Y, Ge Y, Wu Z, Yue X, Li C, et al. Tim-4 alleviates acute hepatic injury by modulating homeostasis and function of NKT cells. Clin Exp Immunol. 2024;218:101\u201310.","journal-title":"Clin Exp Immunol"},{"key":"1908_CR90","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12731","volume":"53","author":"H Wu","year":"2020","unstructured":"Wu H, Chen G, Wang J, Deng M, Yuan F, Gong J. TIM-4 interference in Kupffer cells against CCl4-induced liver fibrosis by mediating Akt1\/mitophagy signalling pathway. Cell Prolif. 2020;53:e12731.","journal-title":"Cell Prolif"},{"key":"1908_CR91","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology. 2022;75:473\u201388.","journal-title":"Hepatology"},{"key":"1908_CR92","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1080\/15548627.2019.1596482","volume":"15","author":"H Wu","year":"2019","unstructured":"Wu H, Wang Y, Li W, Chen H, Du L, Liu D, et al. Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome. Autophagy. 2019;15:1882\u201398.","journal-title":"Autophagy"},{"key":"1908_CR93","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jare.2023.02.012","volume":"55","author":"Y Bi","year":"2024","unstructured":"Bi Y, Liu S, Qin X, Abudureyimu M, Wang L, Zou R, et al. FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner. J Adv Res. 2024;55:45\u201360.","journal-title":"J Adv Res"},{"key":"1908_CR94","doi-asserted-by":"publisher","first-page":"957","DOI":"10.18632\/aging.202211","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Xie Y, Cui Z, Xia T, Wan L, Zhou H, et al. Bnip3 interacts with vimentin, an intermediate filament protein, and regulates autophagy of hepatic stellate cells. Aging. 2021;13:957\u201312.","journal-title":"Aging"},{"key":"1908_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108712","volume":"108","author":"X Zhao","year":"2022","unstructured":"Zhao X, Xue X, Wang C, Wang J, Peng C, Li Y. Emerging roles of Sirtuins in alleviating alcoholic liver disease: a comprehensive review. Int Immunopharmacol. 2022;108:108712.","journal-title":"Int Immunopharmacol"},{"key":"1908_CR96","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7150\/ijbs.19370","volume":"13","author":"RB Ding","year":"2017","unstructured":"Ding RB, Bao J, Deng CX. Emerging roles of SIRT1 in fatty liver diseases. Int J Biol Sci. 2017;13:852\u201367.","journal-title":"Int J Biol Sci"},{"key":"1908_CR97","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/jcp.31069","volume":"238","author":"R Li","year":"2023","unstructured":"Li R, Wang Z, Wang Y, Sun R, Zou B, Tian X, et al. SIRT3 regulates mitophagy in liver fibrosis through deacetylation of PINK1\/NIPSNAP1. J Cell Physiol. 2023;238:2090\u2013102.","journal-title":"J Cell Physiol"},{"key":"1908_CR98","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/cells8091053","volume":"8","author":"A Stacchiotti","year":"2019","unstructured":"Stacchiotti A, Grossi I, Garcia-Gomez R, Patel GA, Salvi A, Lavazza A, et al. Melatonin effects on non-alcoholic fatty liver disease are related to microRNA-34a-5p\/Sirt1 axis and autophagy. Cells. 2019;8:1053.","journal-title":"Cells"},{"key":"1908_CR99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jcp.30529","volume":"237","author":"S Aashaq","year":"2022","unstructured":"Aashaq S, Batool A, Mir SA, Beigh MA, Andrabi KI, Shah ZA. TGF-beta signaling: a recap of SMAD-independent and SMAD-dependent pathways. J Cell Physiol. 2022;237:59\u201385.","journal-title":"J Cell Physiol"},{"key":"1908_CR100","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.2147\/DDDT.S186726","volume":"12","author":"M Mu","year":"2018","unstructured":"Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, et al. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-beta\/Smad signaling pathway. Drug Des Devel Ther. 2018;12:4107\u201315.","journal-title":"Drug Des Devel Ther"},{"key":"1908_CR101","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3343\/alm.2018.38.4.331","volume":"38","author":"HW Moon","year":"2018","unstructured":"Moon HW, Park M, Hur M, Kim H, Choe WH, Yun YM. Usefulness of enhanced liver fibrosis, glycosylation isomer of Mac-2 binding protein, galectin-3, and soluble suppression of tumorigenicity 2 for assessing liver fibrosis in chronic liver diseases. Ann Lab Med. 2018;38:331\u20137.","journal-title":"Ann Lab Med"},{"key":"1908_CR102","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s13071-022-05584-1","volume":"15","author":"P Huang","year":"2022","unstructured":"Huang P, Ma H, Cao Y, Zhan T, Zhang T, Wang X, et al. Activation of primary hepatic stellate cells and liver fibrosis induced by targeting TGF-beta1\/Smad signaling in schistosomiasis in mice. Parasit Vectors. 2022;15:456.","journal-title":"Parasit Vectors"},{"key":"1908_CR103","doi-asserted-by":"publisher","first-page":"14826","DOI":"10.3390\/ijms241914826","volume":"24","author":"JH Lee","year":"2023","unstructured":"Lee JH, Kim KM, Jung EH, Lee HR, Yang JH, Cho SS, et al. Parkin-mediated mitophagy by TGF-beta is connected with hepatic stellate cell activation. Int J Mol Sci. 2023;24:14826.","journal-title":"Int J Mol Sci"},{"key":"1908_CR104","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00535-023-02068-6","volume":"59","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang H, Chen L, Fu K, Yan Y, Liu Z. CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation. J Gastroenterol. 2024;59:229\u201349.","journal-title":"J Gastroenterol"},{"key":"1908_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103159","volume":"72","author":"T Lv","year":"2024","unstructured":"Lv T, Fan X, He C, Zhu S, Xiong X, Yan W, et al. SLC7A11-ROS\/alphaKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression. Redox Biol. 2024;72:103159.","journal-title":"Redox Biol"},{"key":"1908_CR106","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41418-025-01625-1","volume":"33","author":"R Wang","year":"2026","unstructured":"Wang R, Guo G, Zhang R, Li L, Gong Y, Yin L, et al. UFL1-mediated UFMylation antagonizes IFT88 ubiquitination and degradation to maintain ciliary homeostasis. Cell Death Differ. 2026;33:1065\u201380.","journal-title":"Cell Death Differ"},{"key":"1908_CR107","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s44319-024-00092-y","volume":"25","author":"R Hong","year":"2024","unstructured":"Hong R, Tan Y, Tian X, Huang Z, Wang J, Ni H, et al. XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis. EMBO Rep. 2024;25:1055\u201374.","journal-title":"EMBO Rep"},{"key":"1908_CR108","doi-asserted-by":"publisher","first-page":"F278","DOI":"10.1152\/ajprenal.00673.2020","volume":"321","author":"R Fujii","year":"2021","unstructured":"Fujii R, Hasegawa S, Maekawa H, Inoue T, Yoshioka K, Uni R, et al. Decreased IFT88 expression with primary cilia shortening causes mitochondrial dysfunction in cisplatin-induced tubular injury. Am J Physiol Renal Physiol. 2021;321:F278\u2013F92.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1908_CR109","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/hep.24377","volume":"54","author":"BK Chacko","year":"2011","unstructured":"Chacko BK, Srivastava A, Johnson MS, Benavides GA, Chang MJ, Ye Y, et al. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology. 2011;54:153\u201363.","journal-title":"Hepatology"},{"key":"1908_CR110","doi-asserted-by":"crossref","unstructured":"Wu Y, Hao C, Liu X, Han G, Yin J, Zou Z, et al. MitoQ protects against liver injury induced by severe burn plus delayed resuscitation by suppressing the mtDNA-NLRP3 axis. Int Immunopharmacol. 2020;80:106189.","DOI":"10.1016\/j.intimp.2020.106189"},{"key":"1908_CR111","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1515\/med-2021-0394","volume":"16","author":"SD Dou","year":"2021","unstructured":"Dou SD, Zhang JN, Xie XL, Liu T, Hu JL, Jiang XY, et al. MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1\/parkin-mediated mitophagy. Open Med. 2021;16:1718\u201327.","journal-title":"Open Med"},{"key":"1908_CR112","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1478-3231.2010.02250.x","volume":"30","author":"EJ Gane","year":"2010","unstructured":"Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int. 2010;30:1019\u201326.","journal-title":"Liver Int"},{"key":"1908_CR113","doi-asserted-by":"crossref","unstructured":"Liu C, Yang H, Liu Y, An M, Weng Z, Li L. Cell-specific roles of autophagy in liver fibrosis: implications for targeted pharmacotherapy. Ann Med. 2025;57:2601425.","DOI":"10.1080\/07853890.2025.2601425"},{"key":"1908_CR114","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41575-023-00832-w","volume":"20","author":"S Sharma","year":"2023","unstructured":"Sharma S, Le Guillou D, Chen JY. Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20:662\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1908_CR115","doi-asserted-by":"crossref","unstructured":"Jahagirdar V, Rama K, Cabrera D, Idalsoaga F, D\u00edaz LA, Arrese M, et al. Implications of liver fibrosis in clinical trials. Ann Hepatol. 2025;30:102112.","DOI":"10.1016\/j.aohep.2025.102112"},{"key":"1908_CR116","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, et al. The mitophagy pathway and its implications in human diseases. Signal Transd Target Ther. 2023;8:304.","journal-title":"Signal Transd Target Ther"},{"key":"1908_CR117","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10495-024-01977-y","volume":"29","author":"MS D\u2019Arcy","year":"2024","unstructured":"D\u2019Arcy MS. Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implications. Apoptosis. 2024;29:1415\u201328.","journal-title":"Apoptosis"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01908-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01908-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01908-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:02:12Z","timestamp":1786348932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01908-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":117,"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01908-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}